Notice2021-27482
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 20, 2021
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 241 (Monday, December 20, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 241 (Monday, December 20, 2021)]
[Notices]
[Pages 71902-71903]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-27482]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and contract proposals and
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications and
contract proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Review of Radiation Oncology-Biology Integration Network
(ROBIN) Centers.
Date: February 3-4, 2022.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W640, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Saejeong J. Kim, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W640, Rockville, Maryland 20850, 240-276-7684,
<a href="/cdn-cgi/l/email-protection#463527232c23292821682d2f2b06282f2e68212930"><span class="__cf_email__" data-cfemail="1360727679767c7d743d787a7e537d7a7b3d747c65">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Drug Development Support TEP.
Date: February 4, 2022.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W106, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W106, Rockville, Maryland 20850, 240-276-7975,
<a href="/cdn-cgi/l/email-protection#06656e736067686363466b676f6a28686f6e28616970"><span class="__cf_email__" data-cfemail="a0c3c8d5c6c1cec5c5e0cdc1c9cc8ecec9c88ec7cfd6">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-5: NCI Clinical and Translational Cancer Research.
Date: February 8-9, 2022.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W248, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Shree Ram Singh, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W248, Rockville, Maryland 20850, 240-672-6175,
<a href="/cdn-cgi/l/email-protection#5a2933343d322932281a373b333674343332743d352c"><span class="__cf_email__" data-cfemail="e093898e8788938892a08d81898cce8e8988ce878f96">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Metabolic Dysregulation and Cancer Risk.
Date: February 8, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W108, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific
Review Officer, Special Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343,
<a href="/cdn-cgi/l/email-protection#80f3e3e8f7e5e9eee6e5f3f4e3f7c0ede1e9ecaeeee9e8aee7eff6"><span class="__cf_email__" data-cfemail="5f2c3c37283a3631393a2c2b3c281f323e36337131363771383029">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-10: NCI Clinical and Translational Cancer Research.
Date: February 22, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W552, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Biman Chandra Paria, Ph.D., Scientific Review
Officer, Program Coordination and Referral Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9606 Medical
Center Drive, Room 7W552, Rockville, Maryland 20850, 202-731-8506,
<a href="/cdn-cgi/l/email-protection#84f4e5f6ede5e6c4e9e5ede8aaeaedecaae3ebf2"><span class="__cf_email__" data-cfemail="85f5e4f7ece4e7c5e8e4ece9abebecedabe2eaf3">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-7: NCI Clinical and Translational Cancer Research.
Date: February 23-24, 2022.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W104, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Robert F. Gahl, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9606 Medical Center Drive, Room
7W104, Rockville, Maryland 20850, 240-276-7869, <a href="/cdn-cgi/l/email-protection#c3b1aca1a6b1b7eda4a2abaf83adaaabeda4acb5"><span class="__cf_email__" data-cfemail="087a676a6d7a7c266f69606448666160266f677e">[email protected]</span></a>.
Name of Committee: National Cancer Institute Initial Review
Group; Institutional Training and Education Study Section (F).
Date: February 23-24, 2022.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W234, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Adriana Stoica, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W234, Rockville, Maryland 20850, 240-276-6368,
<a href="/cdn-cgi/l/email-protection#edbe9982848e8c8cdfad808c8481c3838485c38a829b"><span class="__cf_email__" data-cfemail="3162455e5852505003715c50585d1f5f58591f565e47">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Research Specialist Award (R50).
Date: February 24-25, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W242, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W242, Rockville, Maryland 20850, 240-276-6372,
<a href="/cdn-cgi/l/email-protection#1e64716b6476776f5e737f77723070777630797168"><span class="__cf_email__" data-cfemail="354f5a404f5d5c447558545c591b5b5c5d1b525a43">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Translational and Basic Research Early Lesions (U54 and U24).
Date: March 2-3, 2022.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W108, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific
Review Officer, Special Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343,
<a href="/cdn-cgi/l/email-protection#4536262d32202c2b2320363126320528242c296b2b2c2d6b222a33"><span class="__cf_email__" data-cfemail="205343485745494e464553544357604d41494c0e4e49480e474f56">[email protected]</span></a>.
Name of Committee: National Cancer Institute Initial Review
Group; Career Development Study Section (J).
Date: March 3-4, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W624, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Tushar Deb, Ph.D., Scientific Review Officer,
Resources and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W624, Rockville, Maryland 20850, 240-276-6132,
<a href="/cdn-cgi/l/email-protection#dfabaaacb7beadf1bbbabd9fb1b6b7f1b8b0a9"><span class="__cf_email__" data-cfemail="e69293958e8794c8828384a6888f8ec8818990">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-4: NCI Clinical and Translational Cancer Research.
Date: March 17, 2022.
Time: 10:00 a.m. to 6:00 p.m.
[[Page 71903]]
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W106, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W106, Rockville, Maryland 20850, 240-276-7975,
<a href="/cdn-cgi/l/email-protection#f5969d8093949b9090b598949c99db9b9c9ddb929a83"><span class="__cf_email__" data-cfemail="80e3e8f5e6e1eee5e5c0ede1e9ecaeeee9e8aee7eff6">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Informatics Technologies for Cancer Research.
Date: March 30-31, 2022.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W114, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W114, Rockville, Maryland 20850, 240-276-6371,
<a href="/cdn-cgi/l/email-protection#d6b2b3b5baa3b3bc96bbb7bfbaf8b8bfbef8b1b9a0"><span class="__cf_email__" data-cfemail="402425232c35252a002d21292c6e2e29286e272f36">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: December 15, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-27482 Filed 12-17-21; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 20, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.